Development and validation of a novel reporter gene assay for determination of recombinant human thrombopoietin

Hitchcock, 2014, Thrombopoietin from beginning to end, Br. J. Haematol., 165, 259, 10.1111/bjh.12772

Zhang, 2016, Thrombopoietin: a potential diagnostic indicator of immune thrombocytopenia in pregnancy, Oncotarget., 7, 7489, 10.18632/oncotarget.7106

Bhat, 2018, A network map of thrombopoietin signaling, J. Cell Commun. Signal., 12, 737, 10.1007/s12079-018-0480-4

Kuter, 2002, Recombinant human thrombopoietin: basic biology and evaluation of clinical studies, Blood., 100, 3457, 10.1182/blood.V100.10.3457

Kato, 1998, Native thrombopoietin: structure and function, Stem Cells., 16, 322, 10.1002/stem.160322

Xia, 2000, Thrombopoietin and the TPO receptorduring platelet storage, Transfusion., 40, 976, 10.1046/j.1537-2995.2000.40080976.x

Wolber, 2002, Thrombopoietin: The Novel Hepatic Hormone, News Physiol. Sci., 17, 6

Kuter, 2013, The biology of thrombopoietin and thrombopoietin receptor agonists, Int. J. Hematol., 98, 10, 10.1007/s12185-013-1382-0

Kuter, 1996, Thrombopoietin: biology and clinical applications, Oncologist., 1, 98, 10.1634/theoncologist.1-1-98

Ghanima, 2019, Thrombopoietin receptor agonists: ten years later, Heamatologica., 104, 1112, 10.3324/haematol.2018.212845

Ninos, 2006, The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietiv stem cells, J. Transl. Med., 16, 4

Kaushansky, 2009, Molecular mechanisms of thrombopoietin signaling, J. Thromb. Haemost., 7, 235, 10.1111/j.1538-7836.2009.03419.x

Ng, 2014, Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation, Proc. Natl. Acad. Sci. USA, 111, 5884, 10.1073/pnas.1404354111

Kumar, 2019, Understanding the journey of human hematopoietic stem cell development, Stem Cells Int., 2019, 2141475, 10.1155/2019/2141475

Palis, 2016, Hematopoietic stem cell-independent hematopoiesis: emergence of erythroid, megakaryocyte, and myeloid potential in the mammalian embryo, FEBS Lett., 590, 3965, 10.1002/1873-3468.12459

Zhang, 2017, Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours, Cochrane Database Syst. Rev., 11, CD012035

Zhou, 2019, The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial, BMC Infect Dis., 19, 780, 10.1186/s12879-019-4388-2

Penington, 1970, Isotope bioassay for “thrombopoietin”, Br. Med. J., 1, 606, 10.1136/bmj.1.5696.606

Lewis, 1974, Cyclic thrombocytopenia: a thrombopoietin deficiency, J. Clin. Pathol., 27, 242, 10.1136/jcp.27.3.242

N. Komatsu, M. Kunitama, M. Yamada, T. Hagiwara, T. Kato, H. Miyazaki, et al. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO. Blood. 87 (1996) 4552–4560.

M.F. Brizzi, E. Battaglia, A. Rosso, P. Strippoli, G. Montrucchio, G. Camussi, et al. Regulation of polymorphonuclear cell activation by thrompoietin. J. Clin. Invest. 99 (1997) 1576–1584.

Ohashi, 1998, Thrombopoietin stimulates proliferation and megakaryicytic differentiation of mouse pro-B cell line BF-TE22, Cytotechnology., 26, 199, 10.1023/A:1007915809529

Erickson-Miller, 2009, Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor r agonist, Stem Cells., 27, 424, 10.1634/stemcells.2008-0366

Page, 1996, A sensitive human cell line based bioassay for megakaryocyte growth and development factor or thrombopoetin, Cytokine., 8, 66, 10.1006/cyto.1996.0009

Zang, 2007, Expression, refolding, and characterization of recombinant thrombopoietin / stem cell factor fusion protein in Eschericha coli, Appl. Microbiol. Biotechnol., 74, 836, 10.1007/s00253-006-0734-6

Zang, 2007, A novel thrombopoietin-stem-cell factor fusion protein possesses enhanced potential in stimulating megakaryocyte proliferation and differentiation, Biotechnol. App. Biochem., 48, 135, 10.1042/BA20070063

Yang, 2014, A novel reporter gene assay for recombinant human erythropoietin (rHuEPO) pharmaceutical products, J. Pharm. Biomed. Anal., 100, 316, 10.1016/j.jpba.2014.08.003

Yao, 2019, A cell-based strategy for bioactivity determination of long-acting Fc-fusion recombinant human growth hormone, Molecules., 24, 1389, 10.3390/molecules24071389

Yao, 2019, Bioactivity determination of a therapeutic recombinant human keratinocyte growth factor by a validated cell-based bioassay, Molecules., 24, 699, 10.3390/molecules24040699

Wang, 2016, Development of a robust reporter-based assay for the bioactivity determination of anti-VEGF therapeutic antibodies, J. Pharm. Biomed. Anal., 125, 212, 10.1016/j.jpba.2016.03.042

Wang, 2017, Development of a robust reporter gene assay to measure the bioactivity of anti-PD-1/ anti-PD-L1 therapeutic antibodies, J. Pharm. Biomed. Anal., 145, 447, 10.1016/j.jpba.2017.05.011

Fu, 2018, Development of a robust reporter gene based assay for the bioactivity determination of IL-5-targeted therapeutic antibodies, J. Pharm. Biomed. Anal., 148, 280, 10.1016/j.jpba.2017.09.032

Qin, 2019, Responsive cells for rhEGF bioassay obtained through screening of a CRISPR/Cas9 library, Sci. Rep., 9, 3780, 10.1038/s41598-019-40381-4

Yu, 2018, Measuring the bioactivity of anti-IL-6/ anti-IL-6R therapeutic antibodies: presentation of a robust reporter gene assay, Anal. Bioanal. Chem., 410, 7067, 10.1007/s00216-018-1307-0

Guo, 2020, A robust and stable reporter gene bioassay for anti-IgE antibodies, Anal. Bioanal. Chem., 412, 1901, 10.1007/s00216-020-02442-w

Wang, 2020, Development of reporter gene assays to determine the bioactivity of biopharmaceuticals, Biotechnol. Adv., 39, 10.1016/j.biotechadv.2019.107466

Niu, 2020, Development of a novel reporter gene assay for platelet-derived growth factor-BB bioactivity, Biologicals., 63, 68, 10.1016/j.biologicals.2019.11.004

Yu, 2019, Development and validation of a reporter-cell- line-based bioassay for therapeutic soluble gp130-Fc, Molecules., 24, 3845, 10.3390/molecules24213845

Li, 2016, Method development and validation for pharmaceutical tablets analysis using transmission Raman spectroscopy, Int. J. Pharm., 498, 318, 10.1016/j.ijpharm.2015.11.049

Hawe, 2012, Forced degradation of therapeutic proteins, J. Pharm. Sci., 101, 895, 10.1002/jps.22812

Kuter, 2013, 1217

T. Kato, Thrombopoietin. Handbook of Hormones., Elservier Inc., Amsterdam, Netherland, 2015, pp. 319–322.

ICH. International Conference on Harmonization (ICH) Guidelines ICH Q2(R1), Validation of Analytical Procedures: Text and Methodology; ICH: Geneva, Switzerland, 2005.

Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia, 5th ed.; People’s Medical Publishing House: Beijing, China, 2020.